Results 61 to 70 of about 16,267 (112)

Comments on “dynamic 18F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer”

Thoracic Cancer, 2022
Shan‐Ying Wang, Yu‐Chien Shiau, Chen‐Xiong Hsu   +2 more
doaj   +1 more source

Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with renal carcinoma: A protocol for systematic review and meta analysis: Erratum. [PDF]

Medicine (Baltimore), 2022
europepmc   +1 more source

¹⁸F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis-The Central Role of Volume. [PDF]

J Nucl Med, 2020
Reynolds JC, Maass-Moreno R, Thomas A, Ling A, Padiernos EB, Steinberg SM, Hassan R.   +6 more
europepmc   +1 more source

Baseline total lesion glycolysis combined with interim positron emission tomography-computed tomography is a robust predictor of outcome in patients with peripheral T-cell lymphoma. [PDF]

Cancer Med, 2020
Kitadate A, Narita K, Fukumoto K, Terao T, Tsushima T, Kobayashi H, Abe Y, Miura D, Takeuchi M, Machida Y, Matsue K.   +10 more
europepmc   +1 more source

Total lesion glycolysis is a promising predictor of chemo-response in pancreatic cancer patients treated with neoadjuvant chemotherapy prior to surgery. [PDF]

Eur J Clin Invest
Byeon S, Abbott B, Roach P, Bailey DL, Chou A, Maloney S, Gill AJ, Samra J, Mittal A, Sahni S.   +9 more
europepmc   +1 more source

¹⁸F-FDG PET/CT total lesion glycolysis is associated with circulating tumor cell counts in patients with stage I to IIIA non-small cell lung cancer. [PDF]

Transl Lung Cancer Res, 2020
Avella DM, Manjunath Y, Singh A, Deroche CB, Kimchi ET, Staveley-O'Carroll KF, Mitchem JB, Kwon E, Li G, Kaifi JT.   +9 more
europepmc   +1 more source

Baseline total lesion glycolysis identifies high-risk patients with immunosuppressive signatures in early-stage natural killer/T-cell lymphoma. [PDF]

Oncologist
Gao X, Xiong J, Huang XY, Yang HX, Zhong HJ, Cheng S, Jiang XF, Zhao WL.   +7 more
europepmc   +1 more source

[¹⁸F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial. [PDF]

Eur J Nucl Med Mol Imaging
Breukers SE, Crommelin RD, Smit LA, de Boer JP, Navran A, van Houdt WJ, de Bree R, Devriese LA, Haanen JBAG, Wondergem M, Zuur CL, Vogel WV.   +11 more
europepmc   +1 more source

The correlation between preoperative total lesion glycolysis and lymphovascular invasion based on ¹⁸F-FDG PET/CT and its predictive value in primary gastric cancer: a cross-sectional study. [PDF]

Quant Imaging Med Surg
Xue XQ, Li XF, Shi X, Wang YT.
europepmc   +1 more source

Correction: Total lesion Glycolysis of primary tumor and lymphnodes is a strong predictor for development of distant metastases in oropharyngeal carcinoma patients with independent validation in automatically delineated lesions. [PDF]

Cancer Imaging
Zschaeck S, Hajiyianni M, Hausmann P, Nikulin P, Kukuk E, Furth C, Cegla P, Lombardo E, Kazmierska J, Holzgreve A, Strouthos I, Stromberger C, Belka C, Baumann M, Krause M, Landry G, Cholewinski W, Kotzerke J, Zips D, van den Hoff J, Hofheinz F.   +20 more
europepmc   +1 more source